Statements of Cash Flows - USD ($)		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss		$ (11,394,170)	$ (7,537,845)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		539,434	551,092
Amortization		21,799	39,976
Amortization of right-of-use assets		327,907	373,219
Inventory reserve		4,100	540
Share-based compensation expense		224,939	193,366
Loan and accrued interest forgiveness on note payable		0	(821,515)
Loss on fixed asset disposition		2,285	3,098
Changes in operating assets and liabilities:
Accounts receivable		6,788	41,532
Inventory		(232,553)	(77,432)
Other assets		295,862	475,993
Accounts payable		65,236	(228,811)
Accrued expenses		(147,073)	(504,799)
Lease liabilities		(383,616)	(413,212)
Other liabilities		(62,911)	(25,987)
Net cash used in operating activities		(10,731,973)	(7,930,785)
Cash flows from investing activities:
Purchases of furniture and equipment		(407,475)	(306,868)
Net cash used in investing activities		(407,475)	(306,868)
Cash flows from financing activities:
Payments of deferred offering costs	[1]	(232,845)	(1,578,643)
Proceeds from issuance of common stock		79,463	31,740,046
Repayment of notes payable		(505,205)	(442,086)
Payments under lease obligations		(23,058)	(20,861)
Net cash (used in) provided by financing activities		(681,645)	29,698,456
Net change in cash and cash equivalents		(11,821,093)	21,460,803
Cash and cash equivalents:
Beginning of year		24,783,029	3,322,226
End of year		12,961,936	24,783,029
Cash paid for:
Interest		13,464	15,865
Income taxes		5,050	800
Non-cash investing and financing activities:
Conversion of convertible preferred stock to common stock		0	55,360,897
Commission costs relating to certain proceeds from issuance of common stock		1,843	0
Prepaid insurance financed with promissory notes		$ 141,298	$ 181,123

[1] Deferred offering costs includes $95 of offering costs charged against certain proceeds from the issuance of common stock.